Zyla Life Sciences Asset Turnover Ratio (EGLT), as of first quarter 2020, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Zyla Life Sciences  (EGLT)
 

Zyla Life Sciences Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Zyla Life Sciences asset turnover ratio, the ability of Zyla Life Sciences's assets to generate revenue in the first quarter 2020, increased sequentially to 0.19 in the first quarter (Mar 31 2020), yet the ratio remained below the average, as EGLT's position remain challenging.

Within sector 210 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the First Quarter 2020 compared to the preceding quarter from 3589 to 3590.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

EGLT Asset Turnover Ratio (Mar 31 2020)
I. Quarter		 (Dec 31 2019)
IV. Quarter		 (Sep 30 2019)
III. Quarter		 (Jun 30 2019)
II. Quarter		 (Mar 31 2019)
I. Quarter
Y / Y Asset Change -13.44 % 276.58 % 229.2 % 135.62 % 137.94 %
Y / Y Revenue Change 204.52 % - 174.57 % 196.04 % 0 %
Asset Turnover Ratio (TTM) 0.19 - 0.3 0.28 0.24
EGLT's Total Ranking # 3590 # 3589 # 3052 # 3584 # 3586
Seq. Asset Change 0.02 % -4.13 % 1.48 % -11.05 % 335.16 %
Seq. Revenue Change - - 1.6 % 251.92 % -26.31 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 211
Healthcare Sector # 518
Overall Market # 3590

Asset Turnover Ratio Statistics
High Average Low
14.74 4.4 0.7
(Jun 30 2016)   (Mar 31 2015)




EGLT Company Profile • Back to EGLT Efficiency Comparisons • Compare EGLT Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Mar 31 2020, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Mar 31 2020 Assets at quarter ending Mar 31 2020
Pacific Biosciences Of California Inc   0.52 $ 90.064  Millions$ 174.860  Millions
Silk Road Medical Inc   0.51 $ 69.521  Millions$ 136.342  Millions
Hologic Inc  0.51 $ 3,324.800  Millions$ 6,524.550  Millions
Heska Corporation  0.50 $ 123.804  Millions$ 245.565  Millions
Soligenix inc   0.50 $ 4.410  Millions$ 8.787  Millions
Illumina Inc   0.50 $ 3,556.000  Millions$ 7,159.750  Millions
Intuitive Surgical Inc   0.49 $ 4,604.300  Millions$ 9,321.800  Millions
Myriad Genetics Inc   0.49 $ 760.800  Millions$ 1,540.825  Millions
Cogent Biosciences Inc   0.49 $ 26.477  Millions$ 53.888  Millions
Enovis Corp  0.49 $ 4,206.633  Millions$ 8,583.232  Millions
Inspire Medical Systems inc   0.49 $ 87.147  Millions$ 178.945  Millions
Iqvia Holdings Inc   0.48 $ 11,158.000  Millions$ 23,072.250  Millions
Seagen Inc   0.48 $ 956.028  Millions$ 1,990.608  Millions
Emergent Biosolutions Inc   0.48 $ 1,107.900  Millions$ 2,315.275  Millions
Agenus Inc  0.48 $ 85.285  Millions$ 179.226  Millions
Boston Scientific Corporation  0.48 $ 13,279.000  Millions$ 27,935.750  Millions
Abbott Laboratories  0.47 $ 32,095.000  Millions$ 67,907.500  Millions
Fulgent Genetics Inc   0.47 $ 34.911  Millions$ 73.916  Millions
Dentsply Sirona Inc   0.47 $ 3,957.300  Millions$ 8,400.850  Millions
Orasure Technologies Inc  0.47 $ 156.079  Millions$ 335.263  Millions
Atricure Inc   0.46 $ 230.066  Millions$ 497.372  Millions
Veracyte Inc   0.46 $ 121.961  Millions$ 263.749  Millions
Nanostring Technologies Inc   0.46 $ 124.485  Millions$ 269.572  Millions
Interpace Biosciences Inc   0.46 $ 27.269  Millions$ 59.330  Millions
Titan Pharmaceuticals Inc   0.46 $ 4.002  Millions$ 8.712  Millions
Abbvie Inc   0.46 $ 34,057.000  Millions$ 74,224.250  Millions
Gw Pharmaceuticals Plc  0.46 $ 392.718  Millions$ 856.814  Millions
Inspiremd Inc   0.45 $ 4.340  Millions$ 9.543  Millions
Surgalign Holdings Inc   0.45 $ 215.382  Millions$ 474.680  Millions
Dmk Pharmaceuticals Corporation  0.45 $ 21.871  Millions$ 48.263  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.